Uma Sinha Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Uma Sinha is Chief Scientific Officer of BridgeBio Pharma, Inc.. Currently has a direct ownership of 16,460 shares of BBIO, which is worth approximately $436,025. The most recent transaction as insider was on Nov 16, 2020, when has been sold 469 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5K
0% 3M change
0% 12M change
Total Value Held $436,025

Uma Sinha Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2020
BUY
Exercise of conversion of derivative security
-
469 Added 2.77%
16,460 Common Stock

Also insider at

EIDX
Eidos Therapeutics, Inc.
Chief Scientific Officer
DNAC
Social Capital Suvretta Holdings Corp. III
US

Uma Sinha

Chief Scientific Officer
Winston Salem, NC

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO